About this trial
Most studies investigating the outcomes of the iliac branched endoprosthesis (IBE) are of relatively small sample sizes. This individual patient data (IPD) analysis is a retrospective analysis of all available individual patient data on treatments of aorto-iliac with the Gore Iliac Branch Endoprosthesis device from previous peer reviewed publications. Corresponding authors and/or sponsors of the trials will be contacted to share the databases if available and to coauthor the publication. Th purpose of the IPD is to gain more robust evidence on the technical and clinical outcomes of the Gore IBE device using the individual patient data from as much publications as possible and to provide a sample size to perform meaningful subgroup analysis on the various outcome parameters.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Patients Treated with the GORE® Iliac Branched Endoprosthesis
Trial design
Other
Retrospective
Treatments tested in this trial
Iliac Branched Endoprosthesis
Procedure/SurgeryIliac Branched Endoprosthesis to treat iliac aneurysm
Treatment groups
Trial outcomes
Primary outcomes
primary patency
The primary endpoint is primary patency of the iliac branched endoprosthesis at 12 months follow-up.
Secondary outcomes
Secondary patency
Secondary outcome is secondary patency at 12 months follow-up
primary patency
Secondary outcome is primary patency at 24 months follow-up
secondary patency
Secondary outcome is secondary patency at 24 months follow-up
primary patency
Secondary outcome is primary patency at 60 months follow-up
Other outcomes
Freedom from reintervention
Freedom from reinterventions throughout latest follow-up
Freedom from aneurysm rupture
Freedom from rupture
abdominal aortic aneurysm mortality
AAA-related mortality
freedom from all-cause mortality
Freedom from all-cause mortality
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Rijnstate Hospital
Lead sponsor
W.L. Gore & Associates, B.V.
Collaborator